Pacific Biosciences of California, Inc. (PACB)

PACB Stock Forecast

Stock Price Forecast

The 8 analysts that cover PACB stock have a consensus rating of "Buy" and an average price target of $2.13, which forecasts a 67.72% increase in the stock price over the next year. The lowest target is $1.25 and the highest is $3.5.

Price Target: $2.13 (+67.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.25	$2.13	$2.00	$3.50
Change	-1.57%	+67.72%	+57.48%	+175.59%

* Price targets were last updated on May 15, 2025.

Analyst Ratings

The average analyst rating for PACB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	2	1
Buy	4	4	4	4	3	3
Hold	6	6	6	6	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Hold Maintains $2 → $1.25	Hold	Maintains	$2 → $1.25	-1.57%	May 15, 2025
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Reiterates $1.8	Buy	Reiterates	$1.8	+41.73%	May 15, 2025
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $3	Strong Buy	Maintains	$3	+136.22%	Apr 10, 2025
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $6 → $2	Buy	Maintains	$6 → $2	+57.48%	Mar 25, 2025
David Westenberg Piper Sandler	Piper Sandler	Hold Reiterates $2.5 → $2	Hold	Reiterates	$2.5 → $2	+57.48%	Feb 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

159.15M

Increased by 3.33%

from 154.01M

Revenue Next Year

188.62M

Increased by 18.52%

from 159.15M

EPS This Year

-1.48

from -1.13

EPS Next Year

-0.53

from -1.48

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	78.89M	130.51M	128.30M	200.52M	154.01M	159.15M	188.62M	232.37M
Revenue Growth	-13.20%	65.43%	-1.69%	56.29%	-23.19%	3.33%	18.52%	23.19%
EPS	0.17	-0.89	-1.40	-1.21	-1.13	-1.48	-0.53	-0.41
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	168.2M	210.8M	268.7M
Avg	159.2M	188.6M	232.4M
Low	148.0M	161.2M	172.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	9.2%	32.5%	42.5%
Avg	3.3%	18.5%	23.2%
Low	-3.9%	1.3%	-8.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.68	-0.40	-0.24
Avg	-1.48	-0.53	-0.41
Low	-1.96	-0.64	-0.56

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.